External Evaluation Committee
Mark Atkinson, University of Florida
Environmental, immunologic, and genetic factors that underlie the inability to form immunological tolerance to the insulin secreting pancreatic beta cells.
Michelle Barton, University of Texas
Basic mechanisms of regulated and aberrant gene expression during development, tissue regeneration and cancer.
Ira Fox, University of Nebraska
Transplant surgeon (liver and pancreas), cell therapies for liver diseases and T1D.
John Hogenesch, University of Pennsylvania
Biology of circadian clocks in the mammal, and the application of functional genomics tools to understanding genome function.
Ron Kahn, Joslin Diabetes Center
Type-2 Diabetes.
Eric Lagasse, University of Pittsburgh.
Novel cell-based therapies for patients suffering from degenerative diseases using stem/progenitor cells.
Ihor Lemischka, Mount Sinai Medical School
Fetal liver and adult bone marrow hematopoietic stem cells.
Mark Mercola, Sanford-Burnham Medical Research Institute
Heart development and regeneration.
Geoff Rosenfeld, UC San Diego
Sensors and signals, transcriptional co-activator and co-repressor complexes.
Massimo Trucco, University of Pittsburgh
Etiology of T1D (autoimmunity), beta-cell apoptosis, derivation of islets from pigs, exploitation of adult stem cells for endocrine pancreas regeneration.
Irving Weissman, Stanford Institute for Stem Cell Biology and Regenerative Medicine
Biology and evolution of stem cells and progenitor cells.
